<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34816207</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-5059</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in global women's health</Title><ISOAbbreviation>Front Glob Womens Health</ISOAbbreviation></Journal><ArticleTitle>Sensitive to Infection but Strong in Defense-Female Sex and the Power of Oestradiol in the COVID-19 Pandemic.</ArticleTitle><Pagination><StartPage>651752</StartPage><MedlinePgn>651752</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">651752</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fgwh.2021.651752</ELocationID><Abstract><AbstractText>The incidence of SARS-CoV2 infections is around 15% higher in premenopausal women compared to age matched men, yet the fatality rate from COVID-19 is significantly higher in men than women for all age strata. Sex differences have also been observed in recent epidemics including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), with SARS-CoV 2 virus infection sex differences appear more dramatic. The regulation and expression of the angiotensin converting enzyme 2 (ACE2) is the key for this special coronavirus SARS-CoV-2 to enter the cell. 17&#x3b2;-oestradiol increases expression level and activity of angiotensin converting enzyme-2 (ACE2) and the alternative signaling pathway of Ang II via the angiotensin II receptor type II (AT2R) and the Mas receptor is more dominant in female sex than in male sex. Maybe a hint to explain the higher infection risk in women. The same hormonal milieu plays a major role in protecting women where morbidity and mortality are concerned, since the dominant female hormone, oestradiol, has immune-modulatory properties that are likely to be protective against virus infections. It is also known that the X chromosome contains the largest number of immune-related genes, potentially conferring an advantage to women in efficient immune responsiveness. Lifestyle factors are also likely to be contributory. Premenopausal women could possibly face higher exposure to infection (hence higher infection rates) because economic conditions are often less favorable for them with less opportunity for home office work because of jobs requiring mandatory attendance. Due to the additional task of childcare, it is likely that contact times with other people will be longer. Women generally make healthier lifestyle choices, thus reducing the disease burden that confers high risk of mortality in COVID-19 infected men. This narrative review aims to present key concepts and knowledge gaps on the effects of oestrogen associated with SARS-CoV2 infection and COVID-19 disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Newson, Manyonda, Lewis, Preissner, Preissner and Seeland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Newson</LastName><ForeName>Louise</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Newson Health Ltd, Winton House, Stratford-upon-Avon, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manyonda</LastName><ForeName>Isaac</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Newson Health Ltd, Winton House, Stratford-upon-Avon, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preissner</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute of Physiology and Science-IT, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Humboldt-Universit&#xe4;t zu Berlin, and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Preissner</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department Oral and Maxillofacial Surgery, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Humboldt-Universit&#xe4;t zu Berlin, and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seeland</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Physiology and Science-IT, Charit&#xe9; - Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin, Humboldt-Universit&#xe4;t zu Berlin, and Berlin Institute of Health, Berlin, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Glob Womens Health</MedlineTA><NlmUniqueID>101776281</NlmUniqueID><ISSNLinking>2673-5059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">hormone therapy</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">oestrogen</Keyword><Keyword MajorTopicYN="N">sex</Keyword></KeywordList><CoiStatement>LN and RL are directors of Newson Health Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>24</Day><Hour>6</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34816207</ArticleId><ArticleId IdType="pmc">PMC8593953</ArticleId><ArticleId IdType="doi">10.3389/fgwh.2021.651752</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Seeland U, Coluzzi F, Simmaco M, Mura C, Bourne PE, Heiland M, et al. . Evidence for treatment with oestradiol for women with SARS-CoV-2 infection. BMC Med. (2020) 18:369. 10.1186/s12916-020-01851-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01851-z</ArticleId><ArticleId IdType="pmc">PMC7685778</ArticleId><ArticleId IdType="pubmed">33234138</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding T, Zhang J, Wang T, Cui P, Chen Z, Jiang J, et al. . Amulti-hospital study in Wuhan, China: protective effects of non-menopause and female hormones on SARS-CoV-2 infection. medRxiv. (2020). 10.1101/2020.03.26.20043943v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.03.26.20043943v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi I, Lleo A, Gershwin ME, Invernizzi P. The X chromosome and immune associated genes. J Autoimmun. (2012) 38:J187&#x2013;92. 10.1016/j.jaut.2011.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2011.11.012</ArticleId><ArticleId IdType="pubmed">22178198</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hyg. (2015) 109:9&#x2013;15. 10.1093/trstmh/tru167</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/tru167</ArticleId><ArticleId IdType="pmc">PMC4447843</ArticleId><ArticleId IdType="pubmed">25573105</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al. . Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The atherosclerosis risk in communities study investigators. N Engl J Med. (1993) 328:1069&#x2013;75. 10.1056/NEJM199304153281501</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199304153281501</ArticleId><ArticleId IdType="pubmed">8384316</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn ME, Karas RH. The protective effects of oestrogen on the cardiovascular system. N Engl J Med. (1999) 340:1801&#x2013;11. 10.1056/NEJM199906103402306</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199906103402306</ArticleId><ArticleId IdType="pubmed">10362825</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. (2020) 20:1742. 10.1186/s12889-020-09826-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09826-8</ArticleId><ArticleId IdType="pmc">PMC7675386</ArticleId><ArticleId IdType="pubmed">33213391</ArticleId></ArticleIdList></Reference><Reference><Citation>Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, et al. . Prognostic factors for severity and mortality in patients infected with COVID-19: a systematic review. PLoS ONE. (2020) 15:e0241955. 10.1371/journal.pone.0241955</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0241955</ArticleId><ArticleId IdType="pmc">PMC7671522</ArticleId><ArticleId IdType="pubmed">33201896</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha J, Qie G, Yao Q, Sun W, Wang C, Zhang Z, et al. . Sex differences on clinical characteristics, severity, and mortality in adult patients with COVID-19: a multicentre retrospective study. Front Med. (2021) 8:607059. 10.3389/fmed.2021.607059</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.607059</ArticleId><ArticleId IdType="pmc">PMC7906985</ArticleId><ArticleId IdType="pubmed">33644092</ArticleId></ArticleIdList></Reference><Reference><Citation>Judah G, Aunger R, Schmidt WP, Michie S, Granger S, Curtis V. Experimental pretesting of hand-washing interventions in a natural setting. Am J Public Health. (2009) 99(Suppl 2):S405&#x2013;11. 10.2105/AJPH.2009.164160</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2009.164160</ArticleId><ArticleId IdType="pmc">PMC4504379</ArticleId><ArticleId IdType="pubmed">19797755</ArticleId></ArticleIdList></Reference><Reference><Citation>Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. (2020) 20:442&#x2013;7. 10.1038/s41577-020-0348-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0348-8</ArticleId><ArticleId IdType="pmc">PMC7288618</ArticleId><ArticleId IdType="pubmed">32528136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleki Dana P, Sadoughi F, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B, et al. . An insight into the sex differences in COVID-19 patients: what are the possible causes? Prehosp Disaster Med. (2020) 35:438&#x2013;41. 10.1017/S1049023X20000837</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1049023X20000837</ArticleId><ArticleId IdType="pmc">PMC7327162</ArticleId><ArticleId IdType="pubmed">32600476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. . Prevalence and severity of corona virus disease (2019) (COVID-19): a systematic review and meta-analysis. J Clin Virol. (2020) 127:104371. 10.1016/j.jcv.2020.104371</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104371</ArticleId><ArticleId IdType="pmc">PMC7195434</ArticleId><ArticleId IdType="pubmed">32315817</ArticleId></ArticleIdList></Reference><Reference><Citation>La Vignera S, Cannarella R, Condorelli RA, Torre F, Aversa A, Calogero AE. Sex-specific SARS-CoV-2 mortality: among hormone-modulated ACE2 expression, risk of venous thromboembolism and hypovitaminosis D. Int J Mol Sci. (2020) 21:2948. 10.3390/ijms21082948</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21082948</ArticleId><ArticleId IdType="pmc">PMC7215653</ArticleId><ArticleId IdType="pubmed">32331343</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. . SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271&#x2013;80.e8. 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho KH, Kim SW, Park JW, Do JY, Kang SH. Effect of sex on clinical outcomes in patients with coronavirus disease: a population-based study. J Clin Med. (2020) 10:38. 10.3390/jcm10010038</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10010038</ArticleId><ArticleId IdType="pmc">PMC7794723</ArticleId><ArticleId IdType="pubmed">33374452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? Int J Mol Sci. (2020) 21:3474. 10.3390/ijms21103474</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103474</ArticleId><ArticleId IdType="pmc">PMC7278991</ArticleId><ArticleId IdType="pubmed">32423094</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaton BP, Cotton AM, Brown CJ. Derivation of consensus inactivation status for X-linked genes from genome-wide studies. Biol Sex Differ. (2015) 6:35. 10.1186/s13293-015-0053-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-015-0053-7</ArticleId><ArticleId IdType="pmc">PMC4696107</ArticleId><ArticleId IdType="pubmed">26719789</ArticleId></ArticleIdList></Reference><Reference><Citation>Erfinanda L, Ravindran K, Kohse F, Gallo K, Preissner R, Walther T, et al. . Oestrogen-mediated upregulation of the Mas receptor contributes to sex differences in acute lung injury and lung vascular barrier regulation. Eur Respir J. (2020) 57:2000921. 10.1183/13993003.00921-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00921-2020</ArticleId><ArticleId IdType="pubmed">32764118</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol. (2007) 293:L272&#x2013;8. 10.1152/ajplung.00174.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00174.2007</ArticleId><ArticleId IdType="pubmed">17575008</ArticleId></ArticleIdList></Reference><Reference><Citation>Speyer CL, Rancilio NJ, McClintock SD, Crawford JD, Gao H, Sarma JV, et al. . Regulatory effects of oestrogen on acute lung inflammation in mice. Am J Physiol Cell Physiol. (2005) 288:C881&#x2013;90. 10.1152/ajpcell.00467.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00467.2004</ArticleId><ArticleId IdType="pubmed">15761213</ArticleId></ArticleIdList></Reference><Reference><Citation>Breithaupt-Faloppa AC, Correia CJ, Prado CM, Stilhano RS, Ureshino RP, Moreira LFP. 17beta-Oestradiol, a potential ally to alleviate SARS-CoV-2 infection. Clinics. (2020) 75:e1980. 10.6061/clinics/2020/e1980</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2020/e1980</ArticleId><ArticleId IdType="pmc">PMC7233687</ArticleId><ArticleId IdType="pubmed">32490931</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalpiaz PL, Lamas AZ, Caliman IF, Ribeiro RF, Jr., Abreu GR, Moyses MR, et al. . Sex hormones promote opposite effects on ACE and ACE2 activity, hypertrophy and cardiac contractility in spontaneously hypertensive rats. PLoS ONE. (2015) 10:e0127515. 10.1371/journal.pone.0127515</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0127515</ArticleId><ArticleId IdType="pmc">PMC4444272</ArticleId><ArticleId IdType="pubmed">26010093</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Baskin GB, Marx PA. Oestrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis. (2000) 182:708&#x2013;15. 10.1086/315776</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315776</ArticleId><ArticleId IdType="pubmed">10950763</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, et al. . FDA-approved selective oestrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med. (2013) 5:190ra79. 10.1126/scitranslmed.3005471</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3005471</ArticleId><ArticleId IdType="pmc">PMC3955358</ArticleId><ArticleId IdType="pubmed">23785035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Du X, Zhang J, Zheng H, Lu X, Wu Q, et al. . Selective inhibition of Ebola entry with selective oestrogen receptor modulators by disrupting the endolysosomal calcium. Sci Rep. (2017) 7:41226. 10.1038/srep41226</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep41226</ArticleId><ArticleId IdType="pmc">PMC5259750</ArticleId><ArticleId IdType="pubmed">28117364</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Klein RS. Sex drives dimorphic immune responses to viral infections. J Immunol. (2017) 198:1782&#x2013;90. 10.4049/jimmunol.1601166</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601166</ArticleId><ArticleId IdType="pmc">PMC5325721</ArticleId><ArticleId IdType="pubmed">28223406</ArticleId></ArticleIdList></Reference><Reference><Citation>Harkonen PL, Vaananen HK. Monocyte-macrophage system as a target for oestrogen and selective oestrogen receptor modulators. Ann N Y Acad Sci. (2006) 1089:218&#x2013;27. 10.1196/annals.1386.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1386.045</ArticleId><ArticleId IdType="pubmed">17261769</ArticleId></ArticleIdList></Reference><Reference><Citation>Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol. (2008) 8:737&#x2013;44. 10.1038/nri2394</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2394</ArticleId><ArticleId IdType="pmc">PMC7097214</ArticleId><ArticleId IdType="pubmed">18728636</ArticleId></ArticleIdList></Reference><Reference><Citation>Holt PG, Strickland DH, Wikstrom ME, Jahnsen FL. Regulation of immunological homeostasis in the respiratory tract. Nat Rev Immunol. (2008) 8:142&#x2013;52. 10.1038/nri2236</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2236</ArticleId><ArticleId IdType="pubmed">18204469</ArticleId></ArticleIdList></Reference><Reference><Citation>Vom Steeg LG, Klein SL. Sex and sex steroids impact influenza pathogenesis across the life course. Semin Immunopathol. (2019) 41:189&#x2013;94. 10.1007/s00281-018-0718-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-018-0718-5</ArticleId><ArticleId IdType="pmc">PMC6370518</ArticleId><ArticleId IdType="pubmed">30298431</ArticleId></ArticleIdList></Reference><Reference><Citation>Trenti A, Tedesco S, Boscaro C, Trevisi L, Bolego C, Cignarella A. Oestrogen, angiogenesis, immunity and cell metabolism: solving the puzzle. Int J Mol Sci. (2018) 19:859. 10.3390/ijms19030859</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030859</ArticleId><ArticleId IdType="pmc">PMC5877720</ArticleId><ArticleId IdType="pubmed">29543707</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16:626&#x2013;38. 10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer J, Jung N, Robinson N, Lehmann C. Sex differences in immune responses to infectious diseases. Infection. (2015) 43:399&#x2013;403. 10.1007/s15010-015-0791-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-015-0791-9</ArticleId><ArticleId IdType="pubmed">25956991</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S. Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol. (2017) 198:4046&#x2013;53. 10.4049/jimmunol.1601896</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601896</ArticleId><ArticleId IdType="pmc">PMC5450662</ArticleId><ArticleId IdType="pubmed">28373583</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Jerkic M, Slutsky AS, Zhang H. Molecular mechanisms of sex bias differences in COVID-19 mortality. Crit Care. (2020) 24:405. 10.1186/s13054-020-03118-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03118-8</ArticleId><ArticleId IdType="pmc">PMC7347256</ArticleId><ArticleId IdType="pubmed">32646459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao S, Zhao J, Zhou J, Zhao S, Hu Y, Hou Y. Modulation of 17beta-oestradiol on the number and cytotoxicity of NK cells in vivo related to MCM and activating receptors. Int Immunopharmacol. (2007) 7:1765&#x2013;75. 10.1016/j.intimp.2007.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2007.09.017</ArticleId><ArticleId IdType="pubmed">17996687</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer PR, Kramer SF, Guan G. 17 beta-oestradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages. Arthritis Rheum. (2004) 50:1967&#x2013;75. 10.1002/art.20309</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20309</ArticleId><ArticleId IdType="pubmed">15188374</ArticleId></ArticleIdList></Reference><Reference><Citation>Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, et al. . Immune cell circulating subsets are affected by gonadal function. Life Sci. (1994) 54:1305&#x2013;12. 10.1016/0024-3205(94)00508-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(94)00508-7</ArticleId><ArticleId IdType="pubmed">8190002</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub RH. The complex role of oestrogens in inflammation. Endocr Rev. (2007) 28:521&#x2013;74. 10.1210/er.2007-0001</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2007-0001</ArticleId><ArticleId IdType="pubmed">17640948</ArticleId></ArticleIdList></Reference><Reference><Citation>Deguchi K, Kamada M, Irahara M, Maegawa M, Yamamoto S, Ohmoto Y, et al. . Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause. (2001) 8:266&#x2013;73. 10.1097/00042192-200107000-00008</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00042192-200107000-00008</ArticleId><ArticleId IdType="pubmed">11449084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada M, Irahara M, Maegawa M, Ohmoto Y, Takeji T, Yasui T, et al. . Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am J Obstet Gynecol. (2001) 184:309&#x2013;14. 10.1067/mob.2001.109940</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mob.2001.109940</ArticleId><ArticleId IdType="pubmed">11228479</ArticleId></ArticleIdList></Reference><Reference><Citation>Vural P, Akgul C, Canbaz M. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women. Pharmacol Res. (2006) 54:298&#x2013;302. 10.1016/j.phrs.2006.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2006.06.006</ArticleId><ArticleId IdType="pubmed">16879975</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasui T, Maegawa M, Tomita J, Miyatani Y, Yamada M, Uemura H, et al. . Changes in serum cytokine concentrations during the menopausal transition. Maturitas. (2007) 56:396&#x2013;403. 10.1016/j.maturitas.2006.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.maturitas.2006.11.002</ArticleId><ArticleId IdType="pubmed">17164077</ArticleId></ArticleIdList></Reference><Reference><Citation>Giefing-Kroll C, Berger P, Lepperdinger G, Grubeck-Loebenstein B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell. (2015) 14:309&#x2013;21. 10.1111/acel.12326</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12326</ArticleId><ArticleId IdType="pmc">PMC4406660</ArticleId><ArticleId IdType="pubmed">25720438</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ. (2020) 370:m3489. 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. medRxiv. (2021). 10.1101/2020.10.19.20214494v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis FM, Bouissou DR, Pereira VM, Camargos AF, dos Reis AM, Santos RA. Angiotensin-(1-7), its receptor Mas, and the angiotensin-converting enzyme type 2 are expressed in the human ovary. Fertil Steril. (2011) 95:176&#x2013;81. 10.1016/j.fertnstert.2010.06.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2010.06.060</ArticleId><ArticleId IdType="pubmed">20674894</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, O'Hara M, Evans S, Agyen L, et al. . Long COVID guidelines need to reflect lived experience. Lancet. (2020) 397:455-457. 10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Dambha-Miller H, Hinton W, Joy M, Feher M, Lusignan Sd. Mortality in COVID-19 amongst women on hormone replacement therapy or combined oral contraception: a cohort study. medRxiv. (2021). 10.1101/2021.02.16.21251853v1</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.16.21251853v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Boardman HM, Hartley L, Eisinga A, Main C, Roque i Figuls M, Bonfill Cosp X, et al. . Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. (2015) CD002229. 10.1002/14651858.CD002229.pub4</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002229.pub4</ArticleId><ArticleId IdType="pmc">PMC10183715</ArticleId><ArticleId IdType="pubmed">25754617</ArticleId></ArticleIdList></Reference><Reference><Citation>Davey DA. Menopausal hormone therapy: a better and safer future. Climacteric. (2018) 21:454&#x2013;61. 10.1080/13697137.2018.1439915</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13697137.2018.1439915</ArticleId><ArticleId IdType="pubmed">29526116</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. (2019) 364:k4810. 10.1136/bmj.k4810</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k4810</ArticleId><ArticleId IdType="pmc">PMC6326068</ArticleId><ArticleId IdType="pubmed">30626577</ArticleId></ArticleIdList></Reference><Reference><Citation>Stute P, Wildt L, Neulen J. The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric. (2018) 21:111&#x2013;22. 10.1080/13697137.2017.1421925</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13697137.2017.1421925</ArticleId><ArticleId IdType="pubmed">29384406</ArticleId></ArticleIdList></Reference><Reference><Citation>Scarabin PY. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal oestrogen meta-analysis. Climacteric. (2018) 21:341&#x2013;5. 10.1080/13697137.2018.1446931</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13697137.2018.1446931</ArticleId><ArticleId IdType="pubmed">29570359</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>